Table 15.4b

Steroid Avoidance Rate at Discharge, 1995 to 2004

Recipients of Living Donor Kidneys

Discharge Regimen Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total Patients 2,943 3,174 3,455 3,874 4,070 4,718 5,184 5,358 5,513 5,611
Steroids Avoided 226 99 106 147 118 263 468 635 1,015 1,574
Rate 7.7% 3.1% 3.1% 3.8% 2.9% 5.6% 9.0% 11.9% 18.4% 28.1%
CyA Patients 403 315 259 232 234 167 123 80 103 123
Steroids Avoided 7 12 14 8 1 4 8 4 10 21
Rate 1.7% 3.8% 5.4% 3.4% 0.4% 2.4% 6.5% 5.0% 9.7% 17.1%
Tac Patients 44 65 87 101 120 204 221 235 192 192
Steroids Avoided 0 2 3 5 5 30 50 89 64 67
Rate 0.0% 3.1% 3.4% 5.0% 4.2% 14.7% 22.6% 37.9% 33.3% 34.9%
CyA+MMF Patients 274 1,296 1,823 1,953 2,046 1,924 1,641 1,298 1,123 939
Steroids Avoided 5 22 25 42 36 64 66 44 111 112
Rate 1.8% 1.7% 1.4% 2.2% 1.8% 3.3% 4.0% 3.4% 9.9% 11.9%
Tac+MMF Patients 23 125 305 763 1,016 1,390 1,973 2,596 2,883 3,311
Steroids Avoided 0 1 7 38 48 74 132 261 477 998
Rate 0.0% 0.8% 2.3% 5.0% 4.7% 5.3% 6.7% 10.1% 16.5% 30.1%
CyA+Aza Patients 1,647 845 581 405 270 186 143 51 20 14
Steroids Avoided 17 20 20 23 7 3 2 0 1 1
Rate 1.0% 2.4% 3.4% 5.7% 2.6% 1.6% 1.4% 0.0% 5.0% 7.1%
Tac+Aza Patients 54 52 43 68 62 59 84 82 70 41
Steroids Avoided 2 1 1 1 3 5 11 6 7 6
Rate 3.7% 1.9% 2.3% 1.5% 4.8% 8.5% 13.1% 7.3% 10.0% 14.6%
Siro+MMF Patients - - - 2 1 45 109 152 153 106
Steroids Avoided - - - 0 0 12 8 6 22 26
Rate - - - 0.0% 0.0% 26.7% 7.3% 3.9% 14.4% 24.5%
CyA+Siro Patients 4 16 45 88 60 260 170 142 169 130
Steroids Avoided 1 0 1 1 0 1 5 30 60 81
Rate 25.0% 0.0% 2.2% 1.1% 0.0% 0.4% 2.9% 21.1% 35.5% 62.3%
Tac+Siro Patients - - - - 6 216 429 382 371 314
Steroids Avoided - - - - 0 22 103 94 115 142
Rate - - - - 0.0% 10.2% 24.0% 24.6% 31.0% 45.2%
Other Regimen Patients 494 460 312 262 255 267 291 340 429 441
Steroids Avoided 194 41 35 29 18 48 83 101 148 120
Rate 39.3% 8.9% 11.2% 11.1% 7.1% 18.0% 28.5% 29.7% 34.5% 27.2%


Source: OPTN/SRTR Data as of May 2, 2005.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressivedrug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;Siro: Sirolimus.